SCHEMBL30833487

SCHEMBL30833487

CC(C)(C)OC(=O)N1CCCCC1C(F)(F)S(=O)(=O)c1ccccc1C=O

nearest known ligand 0.40

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SFRP1 Q8N474 3/20 0.40
WNT3 P56703 2/20 0.40
NR1H2 P55055 2/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
HCRTR2 O43614 1/20 0.37
NR1H3 Q13133 1/20 0.36
KDM4E B2RXH2 2/20 0.36
KDM1A O60341 1/20 0.36
POLB P06746 1/20 0.36
NPC1 O15118 1/20 0.35
UCHL1 P09936 1/20 0.35
GPR119 Q8TDV5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30833463 0.84 MEN1 (0.43) SFRP1WNT3NR1H2MEN1KMT2A
SCHEMBL30833385 0.82 POLB (0.45) SFRP1WNT3NR1H2MEN1KMT2A
SCHEMBL17949316 0.80 GPR119 (0.46) SFRP1MEN1KMT2AKDM4EGPR119
SCHEMBL29530126 0.80 GPR119 (0.46) SFRP1MEN1KMT2AKDM4EGPR119
SCHEMBL30833504 0.80 GPR119 (0.40) SFRP1WNT3NR1H2MEN1KMT2A
SCHEMBL30833512 0.78 WNT3 (0.36) SFRP1WNT3NR1H2MEN1KMT2A
SCHEMBL30833425 0.78 RIPK1 (0.45) SFRP1WNT3NR1H2MEN1KMT2A
SCHEMBL2130470 0.76 TSHR (0.43) NR1H2MEN1KMT2AKDM4EKDM1A
SCHEMBL30833492 0.76 RORC (0.36) SFRP1WNT3KMT2ANPC1
SCHEMBL27223630 0.75 TSHR (0.42) NR1H2MEN1KMT2ANR1H3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118164961-A 4-Methylsulfonyl substituted piperidine urea compounds for the treatment of Dilated Cardiomyopathy (DCM) 迈奥卡迪亚公司 2024-06-11 CN disclosed
CN-111393414-B 4-Methylsulfonyl substituted piperidine urea compounds for the treatment of Dilated Cardiomyopathy (DCM) 迈奥卡迪亚公司 2024-05-07 CN disclosed